Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Surgery. 2013 Aug 6;154(6):1199–1205. doi: 10.1016/j.surg.2013.06.020

Table 1.

Clinicopathologic features of all papillary thyroid cancers with respect to BRAF V600E mutation status based on IHC. LVI- lymphovascular invasion, LN metastasis- central nodal disease.

BRAF+ BRAF− p value
Total 25 12
Male (%) 8(32) 4(33) 1
Age 44 41 0.5
Size (mm) 19 30 0.188
Multifocal (%) 15(60) 6(50) 0.726
Extrathyroidal extension (%) 13(52) 5(42) 0.728
LVI (%) 19(76) 8(67) 0.696
LN metastasis (%) 17(68) 6(50) 0.47